Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

APEC leaders vow to accelerate access to COVID-19 vaccines

Published 07/16/2021, 10:49 AM
Updated 07/16/2021, 11:25 AM
© Reuters. FILE PHOTO: A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken  October 30, 2020. REUTERS/Dado Ruvic/File Photo

(Fixes typo in headline)

WASHINGTON (Reuters) - World leaders said in a statement issued after a virtual meeting of the Asia-Pacific trade group APEC that extensive COVID-19 immunization is a global public good and accelerating access to vaccines is essential to overcoming the crisis.

In a statement posted on the APEC website after a virtual meeting hosted by New Zealand, the leaders of the 21-member grouping vowed to redouble efforts to expand vaccine manufacture and supply and said they would continue to support economies for as long as necessary.

U.S. President Joe Biden, Russia's Vladimir Putin, China's Xi Jinping and other world leaders took part in the meeting seeking collective actions to navigate the COVID-19 pandemic and its economic impacts.

In the statement, the leaders also said they would encourage voluntary transfer of vaccine production technology on mutually agreed terms and said that they must pave the way for safe resumption of cross-border travel, but "without undermining efforts to prevent the spread of COVID-19."

"The pandemic continues to have a devastating impact on our region’s people and economies," the statement said.

"We will only overcome this health emergency by accelerating equitable access to safe, effective, quality-assured, and affordable COVID-19 vaccines," it said.

"We recognize the role of extensive immunization against COVID-19 as a global public good. To that end, we will redouble our efforts to expand vaccine manufacture and supply, support global vaccine sharing efforts, and encourage the voluntary transfer of vaccine production technologies on mutually agreed terms," the statement added. https://www.apec.org/Meeting-Papers/Leaders-Declarations/2021/2021_ILR

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.